Brain nuclear factor kappa B is involved in the corticotropin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats

European Journal of Pharmacology

Volumn 584, Issue 1, 2008, Pages 207-212

  Okada, Shoshiro ^a   Yamaguchi Shima, Naoko ^a   Shimizu, Takahiro ^a   Arai, Junichi ^a   Yorimitsu, Mieko ^a   Yokotani, Kunihiko ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Adrenaline; Brain; Corticotropin releasing factor; Inducible nitric oxide synthase; Noradrenaline; Nuclear factor kappa B; Plasma

Indexed keywords

ADRENALIN; CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NORADRENALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PYRROLIDINE DITHIOCARBAMATE; ROSIGLITAZONE; SN 50;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; HORMONAL REGULATION; MALE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADRENAL MEDULLA; ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; INJECTIONS, INTRAVENTRICULAR; MALE; NEURAL PATHWAYS; NF-KAPPA B; NOREPINEPHRINE; PEPTIDES; PPAR GAMMA; PYRROLIDINES; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; THIAZOLIDINEDIONES; THIOCARBAMATES; TIME FACTORS; UP-REGULATION;

EID: 41149163568     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.01.037     Document Type: Article

References (41)

1. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci. 75 (2004) 639-653
2. Anton A.H., and Sayre D.F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther. 138 (1962) 360-375
3. Baeuerle P.A. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072 (1991) 63-80
4. Boothby M. Specificity of sn50 for NF-kappa B?. Nat. Immunol. 2 (2001) 471-472
5. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappa B activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59 (2000) 13-23
6. Chan J.Y., Wu C.H., Tsai C.Y., Cheng H.L., Dai K.Y., Chan S.H., and Chang A.Y. Transcriptional up-regulation of nitric oxide synthase II by nuclear factor-kappaB at rostral ventrolateral medulla in a rat mevinphos intoxication model of brain stem death. J. Physiol. 581 (2007) 1293-1307
7. Chun K.S., Cha H.H., Shin J.W., Na H.K., Park K.K., Chung W.Y., and Surh Y.J. Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB. Carcinogenesis 25 (2004) 445-454
8. Collino M., Aragno M., Mastrocola R., Gallicchio M., Rosa A.C., Dianzani C., Danni O., Thiemermann C., and Fantozzi R. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 530 (2006) 70-80
9. Colville-Nash P.R., Qureshi S.S., Willis D., and Willoughby D.A. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J. Immunol. 161 (1998) 978-984
10. Das J., Chen C.H., Yang L., Cohn L., Ray P., and Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2 (2001) 45-50
11. Daynes R.A., and Jones D.C. Emerging roles of PPARs in inflammation and immunity. Nat. Rev., Immunol. 2 (2002) 748-759
12. Ghosh S., May M.J., and Kopp E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
13. Han I.O., Kim H.S., Kim H.C., Joe E.H., and Kim W.K. Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells. J. Neurosci. Res. 73 (2003) 659-669
14. Kielian T., and Drew P.D. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J. Neurosci. Res. 71 (2003) 315-325
15. Lee S., and Rivier C. Role played by hypothalamic nuclear factor-k B in alcohol-mediated activation of the rat hypothalamic-pituitary-adrenal axis. Endocrinology 146 (2005) 2006-2014
16. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270 (1995) 12953-12956
17. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., and Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270 (1995) 14255-14258
18. Liu S.F., Ye X., and Malik A.B. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J. Immunol. 159 (1997) 3976-3983
19. Liu D., Liu X.Y., Robinson D., Burnett C., Jackson C., Seele L., Veach R.A., Downs S., Collins R.D., Ballard D.W., and Hawiger J. Suppression of staphylococcal enterotoxin B-induced toxicity by a nuclear import inhibitor. J. Biol. Chem. 279 (2004) 19239-19246
20. Madrigal J.L., Moro M.A., Lizasoain I., Lorenzo P., Castrillo A., Bosca L., and Leza J.C. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappa B-mediated mechanisms. J. Neurochem. 76 (2001) 532-538
21. Marcus J.S., Karackattu S.L., Fleegal M.A., and Sumners C. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Glia 41 (2003) 152-160
22. Muia C., Mazzon E., Maiere D., Zito D., Di Paola R., Domenico S., Crisafulli C., Britti D., and Cuzzocrea S. Pyrrolidine dithiocarbamate reduced experimental periodontitis. Eur. J. Pharmacol. 539 (2006) 205-210
23. Neufeld A.H., and Liu B. Comparison of the signal transduction pathways for the induction of gene expression of nitric oxide synthase-2 in response to two different stimuli. Nitric Oxide 8 (2003) 95-102
24. Nurmi A., Vartiainen N., Pihlaja R., Goldsteins G., Yrjanheikki J., and Koistinaho J. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J. Neurochem. 91 (2004) 755-765
25. Okada S., Yokotani K., and Yokotani K. Inducible nitric oxide synthase is involved in corticotropin-releasing hormone-mediated central sympatho-adrenal outflow in rats. Eur. J. Pharmacol. 477 (2003) 95-100
26. O'Neill L.A., and Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20 (1997) 252-258
27. Paxinos G., and Watson C. In: Paxinos G., and Watson C. (Eds). The Rat Brain in Stereotaxic Coordinates, 3rd (1997), Academic Press, San Diego
28. Pizzi M., and Spano P. Distinct roles of diverse nuclear factor-κB complexes in neuropathological mechanisms. Eur. J. Pharmacol. 545 (2006) 22-28
29. Ramesh V., Thatte H.S., McCarley R.W., and Basheer R. Adenosine and sleep deprivation promote NF-kappaB nuclear translocation in cholinergic basal forebrain. J. Neurochem. 100 (2007) 1351-1363
30. Schreck R., Meier B., Mannel D.N., Droge W., and Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175 (1992) 1181-1194
31. Smith E.M., Dalmeida W., and Hughes T.K. Signaling pathway-related gene expression in neuroimmunoregulation. J. Neuroimmunol. 147 (2004) 138-140
32. Smith E.M., Gregg M., Hashemi F., Schott L., and Hughes T.K. Corticotropin releasing factor (CRF) activation of NF-κB-directed transcription in leukocytes. Cell. Mol. Neurobiol. 26 (2006) 1021-1036
33. Strack A.M., Sawyer W.B., Platt K.B., and Loewy A.D. CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res. 491 (1989) 274-296
34. Sunderman Sr. F.W. Therapeutic properties of sodium diethyldithiocarbamate: its role as an inhibitor in the progression of AIDS. Ann. Clin. Lab. Sci. 21 (1991) 70-81
35. Swanson L.W., and Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci. 6 (1983) 269-324
36. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269 (1994) 4705-4708
37. 1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats. Eur. J. Pharmacol. 419 (2001) 183-189
38. Yu Y., Kang Y.M., Zhang Z.H., Wei S.G., Chu Y., Weiss R.M., and Felder R.B. Increased cyclooxygenase-2 expression in hypothalamic paraventricular nucleus in rats with heart failure: role of nuclear factor kappaB. Hypertension 49 (2007) 511-518
39. Zhao J., and Karalis K.P. Regulation of nuclear factor-κB by corticotropin-releasing hormone in mouse thymocytes. Mol. Endocrinol. 16 (2002) 2561-2570
40. Zhao X., Zhang Y., Strong R., Zhang J., Grotta J.C., and Aronowski J. Distinct patterns of intracerebral hemorrhage-induced alterations in NF-kappaB subunit, iNOS, and COX-2 expression. J. Neurochem. 101 (2007) 652-663
41. Zhou M.L., Shi J.X., Hang C.H., Cheng H.L., Qi X.P., Mao L., Chen K.F., and Yin H.X. Potential contribution of nuclear factor-kappaB to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. J. Cereb. Blood Flow Metab. 27 (2007) 1583-1592